MicroSintesis Inc.

MicroSintesis Inc. is a Canadian company specializing in microbiome solutions for poultry health, focusing on innovative products that enhance intestinal balance and improve feed efficiency during production stress. Founded in 2011 and headquartered in Charlottetown, Canada, MicroSintesis Inc. focuses on developing products that support poultry health.

The company received a Growth round of funding amounting to USD 16. 4 mn from Northern Private Capital in June 2019, which represents the total amount raised in its funding history. The CEO, Hannah McIver, leads the firm, which has executed one deal to date. MicroSintesis specializes in innovative microbiome products, primarily through its flagship offering, Nuvio Poultry.

This product is designed to maintain the natural intestinal balance in poultry during periods of production stress, thereby improving overall health and feed efficiency. Nuvio Poultry functions by utilizing bioactive peptides that inhibit quorum sensing in harmful bacteria, preventing their overgrowth and subsequent pathogenic effects without altering the existing microbial composition of the intestine. The target end-users include poultry producers who operate in high-stress environments, such as those involving transport, diet changes, and a compressed production timeline. MicroSintesis's products are marketed across various regions, focusing on key poultry-producing areas worldwide, ensuring a broad client base that spans multiple geographical markets.

MicroSintesis generates revenue primarily through business-to-business transactions, supplying its Nuvio Poultry product directly to poultry producers. These transactions typically involve bulk orders placed by clients who require consistent and reliable solutions for maintaining flock health. The revenue structure includes standard pricing agreements based on volume and frequency of purchases. Nuvio Poultry, recognized for its effectiveness in enhancing bird health and uniformity, serves as the cornerstone of the company's offerings.

The operational model emphasizes long-term partnerships with clients, fostering loyalty and repeat business while providing essential support for producers in maintaining optimal flock performance. MicroSintesis Inc. plans to utilize the recent funding of USD 16. 4 mn to support the development of new products aimed at enhancing poultry health.

They are targeting expansion into new markets across North America and Europe by 2024 to capture a larger share of the poultry industry. The company aims to launch additional specialized products designed for different poultry health challenges, starting with a new offering scheduled for release in early 2024.